All articles by Samseer M

Samseer M

Clinical trial in UK to assess if aspirin can prevent return of cancer

A clinical trial has started in the UK to determine whether using aspirin can stop cancer from returning, involving around 11,000 people nationwide.

University of Queensland scientists identify potential treatment for dengue fever

Scientists at the University of Queensland, Brisbane, Australia, have identified similarities in how the body reacts to mosquito-borne dengue virus and bacterial infections, marking a significant breakthrough in treatment for Dengue fever.

Canada’s Concordia Healthcare to acquire UK drugmaker Amdipharm for $3.5bn

Ontario-based Concordia Healthcare has entered a definitive agreement with European private equity firm Cinven to acquire UK drugmaker Amdipharm Mercury (AMCo) for approximately $3.5bn.

US firm Purdue acquires VM Pharma’s VM-902A TrkA programme for $213m

US-based firm Purdue Pharma has gained full worldwide development and commercial rights to VM Pharma’s VM-902A, a first-in-class, orally bioavailable, peripherally acting and allosteric selective tropomyosin receptor kinase A (TrkA) inhibitor.

Swedish researchers say impotence drugs do not cause malignant melanoma

Researchers from Sweden’s Umea University have revealed that the use of drugs for impotence will not raise the risk of malignant melanoma, in a collaboration with researchers in Uppsala, Lund and New York.